TABLE 2.
Chip type | Chip role | Chip design | Chip relevance | References |
---|---|---|---|---|
Vortex-GMACS-on-chip | cfDNA extraction from BC patient’s blood samples | microfluidic vortex along with a gradient magnetic-activated cfDNA sorter | analysis of DNA derived from tumor cells | Gwak et al. (2019) |
Microfluidic chips | fast and accurately isolation of CTCs from BC patient’s whole blood | antibody labelled microfluidic chip | recognition of EpCAM in CTCs membrane | Abdulla et al. (2022) |
isolation of single and clustered CTCs from patient’s whole blood | label-free and size-based CTCs sorting | CTCs clusters may have a greater metastatic potential than single CTCs | Zhang et al. (2021) | |
rapid and efficient isolation of HER2+ BC cells | magnetic iron oxide nanoparticles functionalized with the anti-HER2 antibody | isolation of HER2+ SKBR3 BC cell line | Parvin et al. (2023) | |
separation of epithelial and mesenchymal cell-derived EVs | HO-MOFF: EMT-on-chip for EpCAM and CD49f biomarker detection in EVs | evaluation of status of BC and estimation of metastatic risk via EVs-based EMT-index in liquid biopsies | Gwak et al. (2021) | |
capture of EVs derived from HER2+ positive BC cells in patient’s urine | nanochip arranged in herringbone pattern functionalized with anti-HER2 antibody | isolation of EVs from BC patient’s urine | Mun et al. (2024a) | |
EVs isolation in patient’s whole blood | filter-electrochemical chip | multiple surface analysis of EVs; PSMA, EGFR, CD81, and CEA detected as tumor markers of EVs on MCF7, BT474, SKBR3, and MDA-MB-231 BC cell lines | Wang et al. (2023) | |
multiple detection of miRNA biomarkers | chip based on three-segment hybridization | early detection of BC | Gao et al. (2020) | |
detection of BC-derived exosomal mRNA in blood | exosomal mRNA sensing microfluidic chip | detection of HER2gene | Lim et al. (2022) | |
role of fluid shear stress in induction of a more aggressive phenotype in metastatic cells compared to BC cell from primary tumor | modular microfluidic system | phenotype alteration in single and clustered MCF7 ER + BC cells; overexpression of Ki67 and phosphorylation of proteins associated with a more aggressive phenotype in CTCs (p-AKT, p-mTOR, and p-STAT3) | Ortega Quesada et al. (2024) |
Abbreviations: BC, breast cancer; CEA, carcinoembryonic antigen; cfDNA, circulating cell-free tumor DNA; CTCs, circulating tumor cells; EGFR, epidermal growth factor receptor; EMT, epithelial-mesenchymal transition; EpCAM, epithelial cell adhesion molecule; EVs, extracellular vesicles; PSMA, prostate specific membrane antigen.